Medicare Enrolled
Dr. Lambda Msezane, M.D.
Urology Physician · Decatur, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Msezane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Msezane?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Msezane
Dr. Lambda Msezane is an urology physician in Decatur, GA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Msezane performed 2,855 Medicare services across 1,896 unique beneficiaries.
Between the years covered by Open Payments, Dr. Msezane received a total of $10,243 from 52 pharmaceutical and/or device companies across 304 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Msezane is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 29% volume in GA
$10,243 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,855
Medicare services
Top 29% in GA for urology physician
1,896
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~168 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
751 | $2 | $22 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
576 | $90 | $233 |
| PSA test (prostate cancer screening) | 275 | $18 | $109 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
236 | $65 | $165 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 226 | $132 | $964 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
103 | $27 | $58 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
91 | $117 | $350 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
83 | $58 | $696 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
72 | $8 | $78 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
70 | $216 | $409 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
50 | $16 | $231 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
50 | $86 | $255 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
48 | $4 | $146 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
36 | $62 | $136 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
32 | $150 | $1,649 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
22 | $37 | $185 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $140 | $246 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
19 | $65 | $119 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
18 | $280 | $2,184 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $74 | $241 |
| Sex hormone binding globulin level test A blood test that measures the level of sex hormone binding globulin, a protein that binds to sex hormones in the bloodstream. |
16 | $21 | $55 |
| Free testosterone level test A blood test that measures the amount of free testosterone in your body. Free testosterone is the portion of the hormone not bound to proteins and available for use by tissues. |
16 | $25 | $84 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
16 | $25 | $111 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
11 | $19 | $88 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,243
Total received (2018-2024)
Avg $1,463/year across 7 years
Top 23% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
304
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,223 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,122
2023
$1,366
2022
$2,600
2021
$2,331
2020
$540
2019
$677
2018
$1,608
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SRS Medical Systems, Inc.
$234
Sumitomo Pharma America, Inc.
$167
Valencia Technologies Corporation
$156
Dendreon Pharmaceuticals LLC
$134
Medtronic, Inc.
$78
AstraZeneca Pharmaceuticals LP
$75
Janssen Biotech, Inc.
$72
Boston Scientific Corporation
$51
Axonics, Inc.
$44
Myriad Genetic Laboratories, Inc.
$42
COLOPLAST CORP
$21
Antares Pharma, Inc.
$17
Verity Pharmaceuticals Inc.
$16
Olympus America Inc.
$15
Top 3 companies account for 49.7% of 2024 payments
All-time payments by company (2018-2024) ›
Axonics, Inc.
$3,043
Astellas Pharma US Inc
$1,458
SRS Medical Systems, Inc.
$508
Dendreon Pharmaceuticals LLC
$432
Sumitomo Pharma America, Inc.
$417
Myriad Genetic Laboratories, Inc.
$393
PFIZER INC.
$367
Janssen Biotech, Inc.
$245
Myovant Sciences Inc.
$243
UROVANT SCIENCES INC
$232
Teleflex LLC
$212
Medtronic, Inc.
$206
Boston Scientific Corporation
$198
EDAP TECHNOMED INC
$168
Merck Sharp & Dohme LLC
$159
Valencia Technologies Corporation
$156
Accord Healthcare, Inc.
$149
Olympus America Inc.
$140
MEDIVATION FIELD SOLUTIONS LLC
$132
NeoTract Inc.
$122
AstraZeneca Pharmaceuticals LP
$95
Endo Pharmaceuticals Inc.
$89
Ferring Pharmaceuticals Inc.
$84
Caldera Medical, Inc
$83
Bayer HealthCare Pharmaceuticals Inc.
$77
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$74
Axonics Modulation Technologies, Inc.
$71
Rochester Medical Corporation
$62
Amgen Inc.
$55
Bayer Healthcare Pharmaceuticals Inc.
$50
AbbVie, Inc.
$44
BOSTON SCIENTIFIC CORPORATION
$44
Merck Sharp & Dohme Corporation
$43
Coloplast Corp
$41
AngioDynamics, Inc.
$32
COLOPLAST CORP
$32
Travere Therapeutics, Inc.
$30
Acerus Pharmaceuticals Corporation
$27
Allergan, Inc.
$23
ABBVIE INC.
$23
Intuitive Surgical, Inc.
$23
Allergan Inc.
$19
UROGEN PHARMA, INC.
$18
Sun Pharmaceutical Industries Inc.
$18
Avadel Specialty Pharmaceuticals, LLC
$18
Progenics Pharmaceuticals, Inc.
$17
Antares Pharma, Inc.
$17
Verity Pharmaceuticals Inc.
$16
Ethicon US, LLC
$14
180 Medical, Inc.
$12
Janssen Pharmaceuticals, Inc
$9
Retrophin, Inc.
$4
Top 3 companies account for 48.9% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS · AMS 700 · AMS 700 CXR RTE KIT · AVEED · Androgel · Axonics · Axonics r-SNM System · BOTOX · Bulkamid · CAMCEVI · CT3000 Pro Base Unit · Da Vinci Surgical System · Desara · ERLEADA · Erleada · FIRMAGON · GEMTESA · INTERSTIM · JELMYTO · KEYTRUDA · LYNPARZA · LifeVest · LithoVue · Lynx System · MYRBETRIQ · MYRISK · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Noctiva · Nubeqa · ODOMZO (sonidegib) capsules · ORGOVYX · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · REZUM · Rezum Generator · SPACEOAR VUE · STRATAFIX · Spanner Prothetic Stent · SpeediCath · TARCEVA · Thiola · Titan · Trelstar · UROLIFT · Upsylon · UroCuff · UroLift · VESICARE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · eCoin Device Kit · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
175
Per 100K population
23.0
County median income
$77,683
Nearest hospital
EMORY DECATUR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Msezane is a clinical cardiology specialist, with above-average Medicare volume (top 29% in GA), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Msezane experienced with automated urinalysis?
Based on Medicare claims data, Dr. Msezane performed 751 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Msezane receive payments from pharmaceutical companies?
Yes. Dr. Msezane received a total of $10,243 from 52 companies across 304 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Msezane's costs compare to other urology physicians in Decatur?
Dr. Msezane's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Msezane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Decatur
Browse urology physicians in Decatur ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
SRS Medical Systems, Inc. Payments to Doctors
See all physicians who received payments from SRS Medical Systems, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology